Topic

Onivyde (irinotecan liposome)

A collection of 33 issues

Humana's Coverage Criteria for Onivyde (Irinotecan Liposome) in New Jersey: What Counts as "Medically Necessary"?

Answer Box: Humana Onivyde Coverage in New Jersey Onivyde (irinotecan liposome) is covered by Humana Medicare Advantage with prior authorization for FDA-approved pancreatic cancer indications. Medical necessity requires: ECOG performance status 0-1, documented diagnosis, and appropriate line of therapy (first-line NALIRIFOX or second-line post-gemcitabine). Fastest approval: Submit complete PA documentation
5 min read

How to Get Onivyde (Irinotecan Liposome) Covered by Aetna CVS Health in California: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Onivyde Approved by Aetna CVS Health in California Onivyde (irinotecan liposome) requires prior authorization from Aetna CVS Health in California for pancreatic cancer treatment. The fastest path to approval involves submitting a complete PA request with documented medical necessity, prior therapy failures, and performance status. If denied,
6 min read

How to Get Onivyde (Irinotecan Liposome) Covered by Cigna in Michigan: Prior Authorization, Appeals, and Cost Assistance

Answer Box: Getting Onivyde (Irinotecan Liposome) Covered by Cigna in Michigan Quick Path to Approval: Cigna requires prior authorization for Onivyde through Express Scripts/Accredo specialty pharmacy. Your oncologist submits documentation including diagnosis, prior gemcitabine failure, lab results, and ECOG performance status. Standard review takes 2 business days; expedited review
6 min read

Getting Onivyde (Irinotecan Liposome) Covered by Blue Cross Blue Shield in Georgia: A Complete Prior Authorization and Appeal Guide

Quick Answer: Blue Cross Blue Shield Georgia requires prior authorization for Onivyde (irinotecan liposome). Submit documentation showing metastatic pancreatic cancer, prior gemcitabine failure, ECOG 0-1 status, and proposed NALIRIFOX regimen. If denied, file internal appeal within 60 days, then external review through Georgia Department of Insurance within 60 days of
6 min read

How to Get Onivyde (Irinotecan Liposome) Covered by Blue Cross Blue Shield in Washington: Prior Authorization Guide and Appeals Process

Answer Box: Getting Onivyde Covered in Washington Blue Cross Blue Shield in Washington requires prior authorization for Onivyde (irinotecan liposome), typically covering it for metastatic pancreatic cancer when used in combination regimens like NALIRIFOX. Key requirements include ECOG performance status 0-1, documented diagnosis, and detailed clinical justification. If denied, you
6 min read